Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive topline results from CT388-103, a Phase II clinical trial of CT-388, an investigational dual GLP-1/GIP ...
This announcement contains inside information as defined in the UK version of the Market Abuse Regulation (EU) No.596/2014, ...
This announcement contains inside information as defined in the UK version of the Market Abuse Regulation (EU) No.596/2014, which is part of UK domestic law by virtue of the European Union (Withdrawal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results